A detailed history of International Assets Investment Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, International Assets Investment Management, LLC holds 1,642,504 shares of GILD stock, worth $146 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
1,642,504
Previous 19,698 8238.43%
Holding current value
$146 Million
Previous $1.35 Billion 76.03%
% of portfolio
0.89%
Previous 0.13%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$66.59 - $83.99 $108 Million - $136 Million
1,622,806 Added 8238.43%
1,642,504 $324 Million
Q2 2024

Jul 30, 2024

SELL
$63.15 - $72.88 $8,525 - $9,838
-135 Reduced 0.68%
19,698 $1.35 Billion
Q1 2024

Apr 11, 2024

SELL
$71.58 - $87.29 $37,364 - $45,565
-522 Reduced 2.56%
19,833 $1.45 Billion
Q4 2023

Jan 25, 2024

SELL
$73.27 - $83.09 $119 Million - $135 Million
-1,628,627 Reduced 98.77%
20,355 $1.65 Million
Q4 2023

Jan 24, 2024

BUY
$73.27 - $83.09 $121 Million - $137 Million
1,648,982 New
1,648,982 $20.4 Million
Q2 2023

Jul 20, 2023

SELL
$76.01 - $86.7 $37,092 - $42,309
-488 Reduced 0.29%
165,690 $12.8 Million
Q1 2023

Apr 19, 2023

BUY
$77.31 - $88.08 $12.8 Million - $14.6 Million
166,178 New
166,178 $13.8 Million
Q4 2022

Jan 24, 2023

SELL
$62.32 - $89.47 $35,023 - $50,282
-562 Reduced 5.34%
9,970 $0
Q3 2022

Nov 10, 2022

SELL
$59.54 - $68.01 $3.75 Million - $4.28 Million
-63,000 Reduced 85.68%
10,532 $650,000
Q3 2022

Oct 31, 2022

BUY
$59.54 - $68.01 $4.38 Million - $5 Million
73,532 New
73,532 $710,000
Q2 2022

Aug 17, 2022

SELL
$57.72 - $65.01 $389,956 - $439,207
-6,756 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $752,960 - $943,540
-13,000 Reduced 65.8%
6,756 $402,000
Q1 2022

May 03, 2022

BUY
$57.92 - $72.58 $625,709 - $784,081
10,803 Added 120.66%
19,756 $415,000
Q4 2021

Feb 10, 2022

SELL
$64.88 - $73.64 $843,439 - $957,320
-13,000 Reduced 59.22%
8,953 $650,000
Q4 2021

Jan 21, 2022

SELL
$64.88 - $73.64 $1.61 Million - $1.83 Million
-24,820 Reduced 53.06%
21,953 $664,000
Q3 2021

Oct 28, 2021

SELL
$67.69 - $73.03 $1.32 Million - $1.42 Million
-19,438 Reduced 29.36%
46,773 $654,000
Q2 2021

Jul 14, 2021

SELL
$63.47 - $69.35 $3.96 Million - $4.32 Million
-62,316 Reduced 48.48%
66,211 $628,000
Q1 2021

Apr 19, 2021

BUY
$60.0 - $68.46 $4.01 Million - $4.57 Million
66,790 Added 108.18%
128,527 $1.08 Million
Q4 2020

Jan 22, 2021

SELL
$56.65 - $64.55 $7,761 - $8,843
-137 Reduced 0.22%
61,737 $453 Million
Q3 2020

Oct 21, 2020

BUY
$62.1 - $78.08 $49,493 - $62,229
797 Added 1.3%
61,874 $495,000
Q2 2020

Jul 20, 2020

SELL
$72.34 - $84.0 $434,763 - $504,840
-6,010 Reduced 8.96%
61,077 $529,000
Q1 2020

Jul 20, 2020

BUY
$62.63 - $80.22 $4.2 Million - $5.38 Million
67,087 New
67,087 $962,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $112B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track International Assets Investment Management, LLC Portfolio

Follow International Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.